Search results for "Anticoagulation"


 
Results 41 - 50 of about 232 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Long-term anticoagulation after first unprovoked VTE associated with considerable bleeding risk

Results from a systematic review and meta-analysis provide a framework for clinicians and patients to balance the benefits and harms of extended anticoagulation for unprovoked venous thromboembolism (VTE).
https://immattersacp.org/weekly/archives/2021/09/14/4.htm
14 Sep 2021

Patients with atrial fibrillation likely to underestimate bleeding risks of anticoagulants

Women were significantly less likely than men to underestimate their bleeding risk, and a history of bleeding was associated with a threefold increased likelihood of inaccurate perception of bleeding risk, according to a study of atrial fibrillation patients.
https://immattersacp.org/weekly/archives/2021/08/24/2.htm
24 Aug 2021

Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19

A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021

Apixaban associated with lower adverse event rates than warfarin in frail patients with afib

A retrospective observational study used Medicare data to compare outcomes of apixaban, rivaroxaban, and dabigatran with warfarin in patients with atrial fibrillation.
https://immattersacp.org/weekly/archives/2021/07/20/4.htm
20 Jul 2021

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021

Osteoarthritis can ease with easy changes

An optimal regimen starting with nonpharmacologic measures can help patients achieve notable relief.
https://immattersacp.org/archives/2021/05/osteoarthritis-can-ease-with-easy-changes.htm
1 May 2021

Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data

Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021

FDA OKs marketing of devices for snoring, brain protection

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/04/fda-oks-marketing-of-devices-for-snoring-brain-protection.htm
1 Apr 2021

DOACs show better safety, effectiveness than warfarin in patients with valvular afib

As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021

CDC updates guidance on COVID-19, studies show vitamins don't improve outcomes

The CDC offered new guidance on immunocompromised patients and pulse oximetry's accuracy, and recent trials showed that vitamin D, zinc, and ascorbic acid didn't help COVID-19 patients but prophylactic anticoagulation did.
https://immattersacp.org/weekly/archives/2021/02/23/1.htm
23 Feb 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next